deltatrials
Completed PHASE4 NCT00317031

Individually Adapted Therapy of Alcoholism

Individually Adapted Therapy of Alcoholism: Clinical Studies

Sponsor: Central Institute of Mental Health, Mannheim

Conditions Alcoholism
Interventions Acamprosate or Naltrexone
Updated 7 times since 2017 Last updated: Jun 26, 2008 Started: Nov 30, 2002 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This PHASE4 trial investigates Alcoholism and is currently completed. Central Institute of Mental Health, Mannheim leads this study, which shows 7 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jun 2022 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Jun 2022 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Central Institute of Mental Health, Mannheim
  • Dupont Applied Biosciences
  • German Federal Ministry of Education and Research
  • Merck Sharp & Dohme LLC
Data source: Central Institute of Mental Health, Mannheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Freiburg im Breisgau, Germany
  • • Heidelberg, Germany
  • • Mannheim, Germany
  • • Regensburg, Germany
  • • Tübingen, Germany